Rapamycin derivatives and the uses thereof in the treatment of neurological disorders

Details for Australian Patent Application No. 2005319427 (hide)

Owner Wyeth

Inventors Graziani, Edmund Idris; Pong, Kevin; Skotnicki, Jerauld

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2005319427

PCT Pub. Number WO2006/068905

Priority 60/638,004 20.12.04 US

Filing date 15 December 2005

Wipo publication date 29 June 2006

Acceptance publication date 3 November 2011

International Classifications

C07D 498/18 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms

A61K 31/435 (2006.01) - having six-membered rings with one nitrogen as the only ring hetero atom

Event Publications

12 July 2007 PCT application entered the National Phase

  PCT publication WO2006/068905 Priority application(s): WO2006/068905

3 November 2011 Application Accepted

  Published as AU-B-2005319427

1 March 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005319432-GLP-1 analog fusion protein formulations

2005319426-Tetrahydroquinoline analogues as muscarinic agonists